FDA approved Capvaxive for kids 2-17 with chronic conditions like diabetes and heart disease, June 18, 2026. Here’s what families managing pediatric chronic illness need to know.
A New Vaccine Option Is Now Available for Kids with Diabetes, Heart Disease, or Other Chronic Conditions
by | Jun 30, 2026 | Uncategorized | 0 comments
Recent Comments